Please use this identifier to cite or link to this item: https://doi.org/10.3390/tropicalmed4020087
DC FieldValue
dc.titleFactors associated with hepatitis B and C co-infection among HIV-infected patients in Singapore, 2006-2017
dc.contributor.authorChoy, C.Y.
dc.contributor.authorAng, L.W.
dc.contributor.authorNg, O.T.
dc.contributor.authorLeo, Y.S.
dc.contributor.authorWong, C.S.
dc.date.accessioned2021-11-16T04:00:35Z
dc.date.available2021-11-16T04:00:35Z
dc.date.issued2019
dc.identifier.citationChoy, C.Y., Ang, L.W., Ng, O.T., Leo, Y.S., Wong, C.S. (2019). Factors associated with hepatitis B and C co-infection among HIV-infected patients in Singapore, 2006-2017. Tropical Medicine and Infectious Disease 4 (2) : 87. ScholarBank@NUS Repository. https://doi.org/10.3390/tropicalmed4020087
dc.identifier.issn2414-6366
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/206327
dc.description.abstractCo-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) with human immunodeficiency virus (HIV) is associated with increased risk of hepatic complications and mortality. A retrospective study to estimate the proportion of HBV and HCV co-infections in Singapore was conducted using a clinical database. We included 3065 patients who were seen under the Clinical HIV Programme at the largest referral centre for HIV care between 2006 and 2017 and were tested for both HBV and HCV. Factors associated with HIV-HBV and HIV-HCV co-infections were determined using logistic regressions. The majority (86.3%) of HIV-infected patients were mono-infected, while 7.2% were co-infected with HBV, 6.0% with HCV, and 0.5% were co-infected with both HBV and HCV. The most common HCV genotype was GT1 (63%). Factors significantly associated with HBV co-infection in the multivariable model were: Aged 30-49 years and 50-69 years at HIV diagnosis, male gender, and HIV transmission through intravenous drug use (IDU). Independent factors associated with HCV co-infection were: Malay ethnicity, HIV transmission through IDU, and HIV diagnosis between 2006 and 2008. Behavioural risk factors such as IDU, as well as epidemiologic differences associated with co-infection, should inform further studies and interventions aimed at reducing viral hepatitis infection among HIV-infected individuals. © 2019 by the authors.
dc.publisherMDPI AG
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2019
dc.subjectCo-infection
dc.subjectHBV
dc.subjectHCV
dc.subjectHepatitis
dc.subjectHIV
dc.subjectPrevalence
dc.typeArticle
dc.contributor.departmentSAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
dc.contributor.departmentMEDICINE
dc.description.doi10.3390/tropicalmed4020087
dc.description.sourcetitleTropical Medicine and Infectious Disease
dc.description.volume4
dc.description.issue2
dc.description.page87
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_tropicalmed4020087.pdf398.44 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons